Perrigo (PRGO) Competitors $27.20 -0.06 (-0.22%) Closing price 07/3/2025 03:30 PM EasternExtended Trading$27.21 +0.01 (+0.04%) As of 07/3/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PRGO vs. CORT, JAZZ, SUPN, PCRX, NKTR, OMER, ASMB, CPIX, LLY, and JNJShould you be buying Perrigo stock or one of its competitors? The main competitors of Perrigo include Corcept Therapeutics (CORT), Jazz Pharmaceuticals (JAZZ), Supernus Pharmaceuticals (SUPN), Pacira BioSciences (PCRX), Nektar Therapeutics (NKTR), Omeros (OMER), Assembly Biosciences (ASMB), Cumberland Pharmaceuticals (CPIX), Eli Lilly and Company (LLY), and Johnson & Johnson (JNJ). These companies are all part of the "pharmaceuticals" industry. Perrigo vs. Its Competitors Corcept Therapeutics Jazz Pharmaceuticals Supernus Pharmaceuticals Pacira BioSciences Nektar Therapeutics Omeros Assembly Biosciences Cumberland Pharmaceuticals Eli Lilly and Company Johnson & Johnson Corcept Therapeutics (NASDAQ:CORT) and Perrigo (NYSE:PRGO) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, media sentiment, earnings, profitability, valuation, analyst recommendations, institutional ownership and risk. Does the media prefer CORT or PRGO? In the previous week, Corcept Therapeutics had 16 more articles in the media than Perrigo. MarketBeat recorded 23 mentions for Corcept Therapeutics and 7 mentions for Perrigo. Corcept Therapeutics' average media sentiment score of 0.92 beat Perrigo's score of 0.51 indicating that Corcept Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Corcept Therapeutics 13 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Perrigo 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend CORT or PRGO? Corcept Therapeutics presently has a consensus target price of $138.25, indicating a potential upside of 90.30%. Perrigo has a consensus target price of $33.00, indicating a potential upside of 21.32%. Given Corcept Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Corcept Therapeutics is more favorable than Perrigo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Corcept Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00Perrigo 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Which has better valuation and earnings, CORT or PRGO? Corcept Therapeutics has higher earnings, but lower revenue than Perrigo. Perrigo is trading at a lower price-to-earnings ratio than Corcept Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorcept Therapeutics$685.45M11.24$141.21M$1.1662.63Perrigo$4.34B0.86-$171.80M-$1.31-20.76 Do institutionals and insiders believe in CORT or PRGO? 93.6% of Corcept Therapeutics shares are owned by institutional investors. Comparatively, 95.9% of Perrigo shares are owned by institutional investors. 20.8% of Corcept Therapeutics shares are owned by company insiders. Comparatively, 0.7% of Perrigo shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is CORT or PRGO more profitable? Corcept Therapeutics has a net margin of 19.33% compared to Perrigo's net margin of -4.16%. Corcept Therapeutics' return on equity of 20.40% beat Perrigo's return on equity.Company Net Margins Return on Equity Return on Assets Corcept Therapeutics19.33% 20.40% 16.64% Perrigo -4.16%8.93%3.87% Which has more volatility & risk, CORT or PRGO? Corcept Therapeutics has a beta of 0.15, suggesting that its stock price is 85% less volatile than the S&P 500. Comparatively, Perrigo has a beta of 0.45, suggesting that its stock price is 55% less volatile than the S&P 500. SummaryCorcept Therapeutics beats Perrigo on 13 of the 16 factors compared between the two stocks. Get Perrigo News Delivered to You Automatically Sign up to receive the latest news and ratings for PRGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRGO vs. The Competition Export to ExcelMetricPerrigoMED PRODUCTS IndustryMedical SectorNYSE ExchangeMarket Cap$3.74B$10.43B$5.56B$20.68BDividend Yield4.26%2.07%5.22%3.71%P/E Ratio-20.7617.0327.6928.10Price / Sales0.8629.39389.6336.78Price / Cash5.3922.9936.8922.53Price / Book0.863.668.034.58Net Income-$171.80M$235.40M$3.18B$985.54M7 Day Performance2.44%2.15%2.93%2.79%1 Month Performance3.90%1.07%1.72%4.37%1 Year Performance6.92%-10.17%34.39%15.08% Perrigo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRGOPerrigo4.8057 of 5 stars$27.20-0.2%$33.00+21.3%+6.9%$3.74B$4.34B-20.768,379Analyst UpgradeCORTCorcept Therapeutics4.7111 of 5 stars$73.40+0.2%$138.25+88.4%+141.5%$7.78B$685.45M63.28300News CoverageJAZZJazz Pharmaceuticals4.9001 of 5 stars$106.12-0.7%$184.00+73.4%+8.1%$6.42B$4.07B14.152,800Insider TradeSUPNSupernus Pharmaceuticals2.8346 of 5 stars$31.52+1.2%$36.00+14.2%+22.9%$1.76B$661.82M28.40580News CoveragePCRXPacira BioSciences3.4516 of 5 stars$23.90+1.8%$26.44+10.6%+10.2%$1.11B$702.77M-10.48720NKTRNektar Therapeutics4.5885 of 5 stars$25.84+0.3%$84.17+225.7%+27.4%$320.67M$98.43M-2.69220Analyst RevisionHigh Trading VolumeOMEROmeros3.5749 of 5 stars$3.00-6.3%$18.00+500.0%-17.2%$175.77MN/A-1.13210ASMBAssembly Biosciences3.6684 of 5 stars$18.12+4.7%$33.00+82.1%+37.4%$138.44M$28.52M-2.91100News CoverageHigh Trading VolumeCPIXCumberland Pharmaceuticals0.5732 of 5 stars$3.35+28.8%N/A+115.0%$50.12M$37.87M-13.4080News CoverageLLYEli Lilly and Company4.9885 of 5 stars$779.35+0.5%$1,011.61+29.8%-14.8%$738.62B$45.04B63.4147,000Trending NewsJNJJohnson & Johnson4.8465 of 5 stars$152.58+0.1%$170.88+12.0%+6.4%$367.12B$88.82B16.97138,100Positive News Related Companies and Tools Related Companies Corcept Therapeutics Competitors Jazz Pharmaceuticals Competitors Supernus Pharmaceuticals Competitors Pacira BioSciences Competitors Nektar Therapeutics Competitors Omeros Competitors Assembly Biosciences Competitors Cumberland Pharmaceuticals Competitors Eli Lilly and Company Competitors Johnson & Johnson Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:PRGO) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s BIGGEST setup yet.After another undefeated quarter, “Market Wizard” Larry Benedict is sounding the alarm on a $194 trillion mark...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Perrigo Company plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Perrigo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRGO Stock Alerts